Parkinson's disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: -Subjects participating and consented in the Luxembourg Parkinson*s Study. -Subjects of both genders with a full capacity of consent for MRI data collection and analysis. -The participants fall within one of the four targeted groups (Parkinson patients and healthy controls with and without GBA gene mutation) -Use of anti-parkinsonian medication (for PD patients) • Age 18 years or older
Exclusion criteria
Exclusion criteria: -Subjects who are not consented participants in Luxembourg Parkinson*s Study. -Refusal to sign the informed consent for MRI data collection and analysis. -Contraindication for MRI data collection (metal implants, pacemakers, etc...)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Motor task-related brain activity as a function of genotype (with or without GBA mutations) and disease (with or without PD). | — |
Secondary
| Measure | Time frame |
|---|---|
| Reward task-related brain activity as a function of genotype (with or without GBA mutations) and disease (with or without PD). Motor and reward task-related cerebral activity as a function of medication status in PD patients (ON vs. OFF medication). Structural MRI measures as a function of genotype (with or without GBA mutations) and disease (with or without PD). | — |
Countries
Netherlands